G. Gaidano et al., ANALYSIS OF ALTERATIONS OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN CHRONIC LYMPHOCYTIC-LEUKEMIA, The American journal of pathology, 144(6), 1994, pp. 1312-1319
B cell chronic lymphocytic leukemia (B-CLL) represents the most freque
nt adult leukemia in the Western world. The molecular pathogenesis of
B-CLL is largely unknown. Although initial reports on small panels of
cases had suggested a role for Bcl-1 and Bcl-2 oncogene activation in
B-CLL, later investigations failed to confirm these data. Among tumor
suppressor genes, p53 mutations have been reported in a fraction of ca
ses. In this study, we have attempted a conclusive definition of the i
nvolvement of dominantly acting oncogenes (Bcl-1 and Bcl-2) and tumor
suppressor loci (p53, 6q(-)) in 100 cases of B-CLL selected for their
CD5 positivity and Rai's stage (0 to IV). Rearrangements of Bcl-1 and
Bcl-2 and deletions of 6q and 17p were analyzed by Southern blot using
multiple probes. Mutational analysis (single strand conformation poly
morphism and polymerase chain reaction direct sequencing) was used to
assay p53 inactivation. No alterations of Bcl-1 or Bcl-2 were detected
in the 100 cases tested. Mutations of p53 were found in 10/100 cases
without any significant association with clinical stage. Deletions of
6q were present in 4/100 cases. Overall, our data indicate that: 1) co
ntrary to previous reports, Bcl-1 and Bcl-2 rearrangements are not inv
olved in CD5(+) and B-CLL pathogenesis and 2) p53 mutations are presen
t in 10% of cases at all stages of the disease.